-
FLAURA2 phase III trial of AstraZeneca's Tagrisso plus chemotherapy demonstrated a median overall survival in EGFR─mutated advanced lung cancer
09 Sep 2025 10:38 GMT
… ) non-small cell lung cancer (NSCLC).
These results … Lung cancer is broadly split into small cell lung cancer … lung cancer medicines and the next wave of innovations, including Tagrisso and Iressa … improvements for people with lung cancer, including and beyond …
-
Inside AstraZeneca’s long-game strategy in lung cancer
07 Aug 2025 16:13 GMT
… doomed from the outset. The lung cancer treatment Iressa, which targeted the mutation … next generation of EGFR-targeting lung cancer drugs with Tagrisso, now considered … the “backbone” of its lung cancer portfolio.
The precision medicine approach …
-
AstraZeneca announces positive results from FLAURA2 phase III trial of Tagrisso plus chemotherapy to treat EGFR─mutated advanced lung cancer
22 Jul 2025 04:57 GMT
… in EGFR-mutated lung cancer, demonstrating that Tagrisso … Lung cancer is broadly split into small cell lung cancer … lung cancer medicines and the next wave of innovations, including Tagrisso and Iressa … for people with lung cancer, including and beyond …
-
DATROWAY® approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
24 Jun 2025 11:26 GMT
… cell lung cancer
Nearly 2.5 million lung cancer cases … lung cancer medicines and the next wave of innovations, including TAGRISSO and IRESSA … non-small cell lung cancer. Translational Lung Cancer Research. 2015;4 … in non-small lung cancers and its correlation …
-
Phase 1/2 Trial Investigating ATR-04 for EGFRi-Related Rashes in Lung Cancer
28 May 2025 22:23 GMT
… patients with non-small cell lung cancer, colorectal cancer and others, … , such as non-small cell lung cancer, colorectal cancer, pancreatic cancer, … Vectibix (panitumumab), Tarceva (erlotinib) and Iressa (gefitinib) — are effective cancer therapies …
-
Elucidating the Role of FASN in Lung Cancer Stem Cells in Sensitive and Resistant EGFR-Mutated Non-Small Cell Lung Cancer Cells
27 May 2025 12:02 GMT
… in patients with lung cancer harboring EGFR mutations … NSCLC, non-small cell lung cancer; PCL-ES, polycaprolactone … summary: gefitinib (ZD1839) (Iressa®) tablets. Oncologist. 2003 … al. Three-dimensional lung tumor microenvironment modulates therapeutic …
-
EU approves AstraZeneca's Imfinzi─in combo with chemotherapy to treat patients with resectable non─small cell lung cancer
05 Apr 2025 07:44 GMT
… Lung cancer is broadly split into NSCLC and small cell lung cancer … portfolio includes leading lung cancer medicines and the … including Tagrisso (osimertinib) and Iressa (gefitinib); Imfinzi and … improvements for people with lung cancer, including and beyond …
-
Vokes Explores Biomarker Testing and Treatment Landscape for EGFR-Mutated Lung Cancer
18 Mar 2025 17:02 GMT
… patients with non–small cell lung cancer (NSCLC)?
VOKES: The … In] patients with metastatic lung cancer who have a targetable driver … we switched to gefitinib [Iressa] because there were better … of Lung Cancer global survey on molecular testing in lung cancer. J …
-
EU approves AstraZeneca's Imfinzi as monotherapy to treat adults with limited─stage small cell lung cancer
18 Mar 2025 13:14 GMT
… limited-stage small cell lung cancer (LS-SCLC) whose … portfolio includes leading lung cancer medicines and the … including Tagrisso (osimertinib) and Iressa (gefitinib); Imfinzi and Imjudo … improvements for people with lung cancer, including and beyond …
-
EMA committee recommends approval of AstraZeneca's Imfinzi in combo with chemotherapy to treat resectable non─small cell lung cancer
04 Mar 2025 07:39 GMT
… Lung cancer is broadly split into NSCLC and small cell lung cancer … portfolio includes leading lung cancer medicines and the … including Tagrisso (osimertinib) and Iressa (gefitinib); Imfinzi and … improvements for people with lung cancer, including and beyond …
About
© 1995-2025